Cours de Vectorologie : Lectines & Ciblage Cellulaire Christian Girard, M. Cf. ENSCP –––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– Si vous avez quelques difficultés à obtenir certains articles, n’hésitez pas à m’écrire pour obtenir quelques fichiers PDF (pour usage personnel seulement, droits d’auteur obligent) à :
[email protected] ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Références choisies (liste non exhaustive) – Références Générales 1. Gene therapy : designer promoters for tumour targeting ; Dirk M. Nettelbeck, Valérie Jérôme, Rolf Müller Trends in Gene Therapy 2000, 16, 174-181. 2. Biomedical applications of nanotechnology – implications for drug targeting and gene therapy ; S. S. Davis Trends in Biotechnology 1997, 15, 217-224. 3. Controlling the vasculature : angiogenesis, anti-angiogenesis and vascular targeting of gene therapy ; T.-P. D. Fan, R. Jaggar, R. Bicknell Trends in Pharmacological Sciences 1995, 16, 57-66. 4. Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition ; Halina Lis, Nathan Sharon Chemical Reviews 1998, 98, 637-674.
– Acide folique 5. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells ; Susan Wang, Philip S. Low Journal of Controlled Release 1998, 53, 39–48. 6. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol ; S. Wang, R. J. Lee, G. Cauchon, D. G. Gorenstein, P. S. Low Proceedings of the National Academy of Sciences USA 1995, 92, 3318-3322. 7. Peptide-Mediated Release of Folate-Targeted Liposome Contents from Endosomal Compartments ; Karen Vogel, Susan Wang, Robert J. Lee, Jean Chmielewski, Philip S. Low Journal of the American Chemical Society 1996, 118, 1581-1586. 8. Targeted Drug Delivery to Chemoresistant Cells: Folic Acid Derivatization of FdUMP[10] Enhances Cytotoxicity toward 5-FU-Resistant Human Colorectal Tumor Cells ; Jinqian Liu, Carol Kolar, Terrence A. Lawson, William H. Gmeiner J. Org. Chem. 2001, 66, 5655-5663.
– Facteurs de Croissance 9. A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer ; João N. Moreira, Christian B. Hansen, Rogério Gaspar, Theresa M. Allen Biochimica et Biophysica Acta (Biomembranes) 2001, 1514, 303-317. 10. Targeting Stealth liposomes in a murine model of human small cell lung cancer ; João N. Moreira, Rogério Gaspar, Theresa M. Allen Biochimica et Biophysica Acta (Biomembranes) 2001, 1515, 167-176. 11. Targeting Endothelial Cells Overexpressing VEGFR-2: Selective Toxicity of Shiga-like Toxin-VEGF Fusion Proteins ; Marina V. Backer, Joseph M. Backer Bioconjugate Chemistry 2001, 12, 1066-1073. 12. Boronated Epidermal Growth Factor as a Potential Targeting Agent for Boron Neutron Capture Therapy of Brain Tumors ; Jacek Capala, Rolf F. Barth, Moïse Bendayan, Michel Lauzon, Dianne M. Adams, Albert H. Soloway, Robert A. Fenstermaker, Jörgen Carlsso Bioconjugate Chemistry 1996, 7, 7-15.
– Séquence RGD 13. Intervesicle Cross-Linking with Integrin aIIbb3 and Cyclic-RGD-Lipopeptide. A Model of Cell-Adhesion Processes ; Bin Hu, Dirk Finsinger, Kai Peter, Zeno Guttenberg, Michael Bärmann, Horst Kessler, Achim Escherich, Luis Moroder, Jochen Böhm, Wolfgang Baumeister, Sen-fang Sui, Erich Sackmann Biochemistry 2000, 39, 12284-12294. 14. Determination of the Binding Specificity of an Integral Membrane Protein by Saturation Transfer Difference NMR: RGD Peptide Ligands Binding to Integrin aIIbb3 ; Robert Meinecke, Bernd Meyer Journal of Medicinal Chemistry 2001, 44, 3059-3065. 15. Solution Structures and Integrin Binding Activities of an RGD Peptide with Two Isomers ; Nuria Assa-Munt, Xin Jia, Pirjo Laakkonen, Erkki Ruoslahti Biochemistry 2001, 40, 23732378 16. Amino Acids and Peptides.Part 39:A Bivalent Poly(ethylene glycol)Hybrid Containing an Active Site (RGD)and Its Synergistic Site (PHSRN)of Fibronectin ; Keiko Hojo, Yuichi Susuki, Mitsuko Maeda, Ikuko Okazaki, Motoyoshi Nomizu, Haruhiko Kamada, Yoko Yamamoto, Shinsaku Nakagawa, Tadanori Mayumi, Koichi Kawasaki Bioorganic & Medicinal Chemistry Letters 2001, 11, 1429-1432. 17. Potent Integrin Antagonists from a Small Library of RGD-Including Cyclic Pseudopeptides ; Laura Belvisi, Anna Bernardi, Anna Checchia, Leonardo Manzoni, Donatella Potenza, Carlo Scolastico, Massimo Castorina, Amelia Cupelli, Giuseppe Giannini, Paolo Carminati, Claudio Pisano Organic Letters 2001, 3, 1001-1004.
– Lectines et Sélectines 18. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells ; Yoshie Maitani , Kumi Kawano , Kazuyo Yamada , Tsuneji Nagai , Kozo Takayama Journal of Controlled Release 2001, 75, 381–389. 19. Lactose-Poly(ethylene Glycol)-Grafted Poly-L-Lysine as Hepatoma Cell-Targeted Gene Carrier ; Young Hun Choi, Feng Liu, Jong Sang Park, Sung Wan Kim Bioconjugate Chemistry 1998, 9, 708-718. 20. Sialyl Lewis x Liposomes as a Multivalent Ligand and Inhibitor of E-Selectin Mediated Cellular Adhesion ; Shawn A DeFrees, Laurie Phillips, Luke Guo, Samuel Zalipsky Journal of the American Chemical Society 1996, 118, 6101-6104. 21. Poly(ethylene glycol)-Grafted Liposomes with Oligopeptide or Oligosaccharide Ligands Appended to the Termini of the Polymer Chains ; Samuel Zalipsky, Nasreen Mullah, Jennifer A. Harding, Joshua Gittelman, Luke Guo, Shawn A. DeFrees Bioconjugate Chemistry 1997, 8, 111-118. 22. Selectin-Carbohydrate Interactions: From Natural Ligands to Designed Mimics ; Eric E. Simanek, Glenn J. McGarvey, Jill A. Jablonowski, Chi-Huey Wong Chemical Reviews 1998, 98, 833-862.
NOTA BENE : Il y a également plusieurs autres publications sur ces sujets et également sur le ciblage de médicaments basé sur les mêmes principes de base. Je vous conseille donc fortement de faire votre bibliographie si vous avez besoin de cerner le sujet dans le cadre de vos stages de microthèse ou DEA ou encore durant votre thése. Bonne lecture et culture !
V{Ü|áà|tÇ Z|ÜtÜw
